About Michael Monheit
Monheit is the managing lawyer at Monheit Law, outside Philadelphia, Pennsylvania. He has practiced law since 1989. Michael Monheit was the managing attorney of the law offices of Herbert Monheit — now Silverman and Fodera — a firm founded by Herbert Monheit in 1963. He is also the managing attorney in charge of all Internet business development for the law firm of Anapol Schwartz Weiss Cohan Feldman and Smalley. Mr. Monheit currently is the chairman of the Fosamax Litigation Group for the American Association for Justice, and he serves on the AAJ Marketing and Client Services Committee. Monheit Law, P.C., concentrates its practice in the field of personal injury cases on a contingency fee basis. During his legal career, Michael Monheit has successfully prosecuted thousands of cases; at present, he is focusing his practice on complex cases involving defective health care and pharmaceutical products. He has developed a national reputation, following his involvement in latex allergy litigation as a member of the Plaintiff’s Steering and Executive Committee in MDL (multidistrict litigation) 1148. Michael Monheit was also lead counsel in class action lawsuits involving childhood lead paint poisoning against public housing authorities — including the Philadelphia Housing Authority — and claims against the lead paint industry. Michael Monheit is an active member of various social networks, including Facebook, LawGuru, LinkedIn, SlideShare, and Blogger.
February 19, 2012 in Birth Defects
| No Comments »
Pregnancy is a frightening time for many expectant moms. There are so many unknowns. However, if you are an expectant mom who is also taking Topamax to treat seizures then you likely have additional concerns. Specifically, you likely want to know if pregnancy and Topamax are compatible or if you will be putting your unborn [...]
February 19, 2012 in Unsafe Drugs
| No Comments »
Before you take any drug, you likely consider the potential benefits and the potential side effects so that you can make an educated decision about whether the taking the drug is in your best interest. Deciding to take Fosamax to treat osteoporosis is no different.
February 11, 2012 in Unsafe Drugs
| 1 Comment »
How that question is answered may depend on who ask. DMAA, or dimethylamylamine, is an active ingredient in products such as OxyElite Pro and Jack3d. In the United States, these products are marketed to athletes and fitness buffs as supplements that increase energy, concentration and metabolism.
February 11, 2012 in Auto Accidents
| No Comments »
It is hard to take even a short trip in Pennsylvania without seeing a truck. Shipping trucks on highways, 18 wheelers making deliveries on local streets and big rigs in parking lots can all create potentially dangerous situations for other drivers and their passengers.
February 6, 2012 in Auto Accidents
| No Comments »
Auto accidents in the suburbs tend to be different than car crashes in the city. While the rules of the road and the laws governing recoveries are the same, there are some practical differences that are important to know about if you are injured in a suburban crash.
February 3, 2012 in Consumer Protection, Product Liability Law
| No Comments »
Metal on metal hip replacements were designed to decrease the number of fractures suffered by hip replacement patients and to avoid other potential problems. However, in the past few years reports of potentially serious metal on metal hip replacement complaints have been reported.
February 3, 2012 in Consumer Protection, Product Liability Law
| No Comments »
You consent to vaginal mesh surgery with the expectation that it will improve your life. Yet, after surgery you find that you are suffering from problems you didn’t anticipate.
January 30, 2012 in Legal Information
Tags: Data Monitoring Committee, FDA Reports, fda testing, Pharmaceutical Liability, pharmaceutical litigation | No Comments »
Late last year Novartis announced termination of ALTITUDE study with Rasilez®/ Tekturna® in high-risk patients with diabetes and renal impairment; 8,609 patients from 36 countries were involved.
January 20, 2012 in Unsafe Drugs
| No Comments »
The answer to the question, “is Actos off the market” is dependent on which market you are talking about. Despite warnings, the FDA has allowed Actos to remain on the market in the United States. Yet, several European countries including France and Germany have taken Actos off the market at least in part because of [...]
January 12, 2012 in Legal Information
Tags: Concussion Lawsuits, Lawsuits for retired NFL players, NFL Concussion Lawsuits, NFL Lawsuits, Sports Accidents | No Comments »
Imagine that you worked many years for an employer — for good pay — only to find after retirement that your job exposed you to long-term health risks, including brain injury. Your former bosses protest that you were compensated well enough during your professional years that you need no additional compensation. Where do you turn?